Avidity Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Avidity Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q2 2020 to Q3 2024.
  • Avidity Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $6.3M, a 29.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $6.3M -$2.61M -29.3% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $6.97M -$788K -10.2% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $7.63M -$634K -7.68% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $8.27M -$484K -5.53% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $8.91M -$357K -3.85% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $7.76M -$1.99M -20.4% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $8.26M -$2M -19.5% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $8.76M -$2.03M -18.8% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $9.26M +$9.22M +20487% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $9.75M +$9.57M +5255% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $10.3M +$9.94M +3125% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $10.8M +$10.3M +2275% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $45K -$328K -87.9% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $182K -$301K -62.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $318K Mar 31, 2021 10-Q 2021-05-12
Q4 2020 $454K Dec 31, 2020 10-K 2022-03-01
Q3 2020 $373K Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $483K Jun 30, 2020 10-Q 2020-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.